Ambu A/S   Report issue

For profit Phase 4
Founded: Copenhagen Denmark (1937)
Status: No NME R&D (1937)

Organization Overview

First Clinical Trial
2019
NCT04033562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Ambu A/S

Active Ingredients

Drugs in Phase 4 Trials (1)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Opioid-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1